Related Experiment Video
Updated: Apr 29, 2026

07:46
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
Published on: June 18, 2018
11.6K
Interactions between cell adhesion and the synaptic vesicle cycle in Parkinson's disease
1Visage Communications, Inc., USA.
Medical Hypotheses
|May 20, 2014
Summary
Parkinson's disease may stem from synaptic dysfunction due to genetic variations affecting cell adhesion. These variations impact neuronal structure and vesicle cycling, potentially explaining neurodegeneration selectivity.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Synaptic dysfunction is an early sign of Parkinson's disease (PD).
- Synapses rely on cell adhesion for neuronal structure, function, and the synaptic vesicle cycle.
- Genome-wide association studies (GWAS) reveal single nucleotide polymorphisms (SNPs) in cell adhesion pathways in PD patients.
Purpose of the Study:
- To hypothesize that PD results from synaptic dysfunction caused by genetic variations in cell adhesion pathways.
- To explore the role of actin and microtubule proteins in the synaptic vesicle cycle in PD.
- To investigate why pacemaker-like neurons are selectively affected in PD.
Main Methods:
- Review of existing literature on synaptic function, cell adhesion, and PD genetics.
- Analysis of pathway data from GWAS in Parkinson's disease.
- Hypothetical modeling of cellular mechanisms in neurodegeneration.
Main Results:
- Genetic variations in cell adhesion pathways are frequently found in PD.
- Actin and microtubule proteins are critical for synaptic vesicle cycling and neuronal integrity.
- Pacemaker-like neurons may be more sensitive to cell adhesion pathway dysfunction.
Conclusions:
- Parkinson's disease may be linked to synaptic dysfunction driven by genetic variations in cell adhesion pathways.
- Actin's role in vesicle recruitment might explain selective neurodegeneration in PD.
- Further research into cell adhesion and cytoskeletal proteins is crucial for understanding PD pathogenesis.
More Related Videos
Related Concept Videos
Parkinson Disease ll: Pathophysiology
26
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
26
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Fusion of Secretory Vesicles with the Plasma Membrane
15.9K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
15.9K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Neural Regulation
34.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.7K

